Malta - Engels - Medicines Authority

fresenius kabi deutschland gmbh else-kroener strasse 1, bad homburg v.d.h. 61352, germany - calcium folinate - solution for infusion or injection - calcium folinate 10.8 mg/ml - all other therapeutic products

Malta - Engels - Medicines Authority

fresenius kabi deutschland gmbh else-kroener strasse 1, bad homburg v.d.h. 61352, germany - calcium folinate - solution for infusion or injection - calcium folinate 10.8 mg/ml - all other therapeutic products

Tsjechië - Tsjechisch - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

b.v.p. (ballinskelligs veterinary products) - vápník, kombinace s vitaminem d a / nebo jinými léky - injekční roztok - vÁpnÍk - skot

Tsjechië - Tsjechisch - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

v.m.d. n.v. - vápník (různé soli v kombinaci) - injekční roztok - vápník - koně, skot, prasata, ovce, kozy

Tsjechië - Tsjechisch - SUKL (Státní ústav pro kontrolu léčiv)

zentiva, k.s., praha array - 1174 chlorid draselnÝ - injekční roztok - 75mg/ml - chlorid draselnÝ

Frankrijk - Frans - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

arrow generiques - calcium élément 500 mg sous forme de : carbonate de calcium 1250 mg - comprimé - 500 mg - pour un comprimé > calcium élément 500 mg sous forme de : carbonate de calcium 1250 mg - calcium / element mineral - calcium / element mineral(a: appareil digestif et métabolisme)ce médicament contient du calcium. il est indiqué : en cas de carence en calcium suite à une augmentation des besoins (croissance, grossesse, allaitement) ;, en traitement d'appoint des décalcifications osseuses chez le sujet âgé, ou après la ménopause, une corticothérapie, une immobilisation prolongée après reprise de la mobilité.

Tsjechië - Tsjechisch - SUKL (Státní ústav pro kontrolu léčiv)

panpharma, luitré array - 1885 sodnÁ sŮl thiopentalu - prášek pro injekční roztok - 0,5g - thiopental

Tsjechië - Tsjechisch - SUKL (Státní ústav pro kontrolu léčiv)

panpharma, luitré array - 1885 sodnÁ sŮl thiopentalu - prášek pro injekční roztok - 1g - thiopental

Verenigde Staten - Engels - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c: calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.

Verenigde Staten - Engels - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. a c